LA BioMed research briefs

VaxGen, Inc. announced recently that the award of a contract to supply 75 million doses of a recombinant anthrax vaccine to the U.S. government will be announced November 5. VaxGen believes it is the only company currently negotiating with the U.S. government to supply the vaccine. If awarded, this contract would constitute the first purchase of vaccine under the Project Bioshield Act of 2004, which was signed into law in July.

VaxGen has been developing its anthrax vaccine candidate, rPA102, to address the urgent need for a modern recombinant vaccine, based on a single defined protein, that has a strong safety profile and which provides protective immunity when administered in a three-dose schedule. The present vaccine requires the administration of six doses.

The UCLA Center for Vaccine Research, located at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) in Torrance, California, is currently participating in a VaxGen rPA102 vaccine research study. The current study is designed to find the anthrax vaccine formulation that will provide the best safety profile (or fewest side effects), while providing the highest level of protection (or best immune response) against anthrax. In the current study, 45 healthy adults were enrolled at the Vaccine Center. The Center is hoping to participate in future studies to determine the best vaccine schedule.

For information about future anthrax studies or the testing of this vaccine, contact the Director of the UCLA Center for Vaccine Research, Joel I.Ward, MD, at 1-800-637-8860.

Dr. Chad K. Oh co-authors "How to Live with a Nut Allergy"

Dr. Chad K.Oh, a principal investigator at LA BioMed, has co-authored a new book titled "How to Live with a Nut Allergy" (McGraw-Hill, $14.95). Every year, 100 Americans die after eating nuts or peanuts. For the 1.5 million Americans living with nut allergies, even slight exposure, such as eating with a fork t

Contact: David Feuerherd
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)

Page: 1 2 3

Related medicine news :

1. LA BioMed medical/research briefs March 2005
2. LA BioMed medical/research briefs January 2005
3. LA BioMed Medical/Research briefs January 2005
4. LA BioMed Medical/Research Briefs December 2004
5. BioMed Central -- freedom of information for the science community
6. Public morally obliged to take part in scientific research, says leading ethicist
7. U of M researcher says Viagra may cause permanent vision loss in some men
8. Indiana University researchers closer to helping hearing-impaired using stem cells
9. Can you read my mind? W.M. Keck Foundation funds innovative brain research at Carnegie Mellon
10. RIT takes eye-tracking research to next level
11. UW research shows risk factors for relapse among health care professionals who abuse drugs

Post Your Comments:

(Date:9/3/2020)... (PRWEB) , ... September 03, 2020 , ... ... of Approval for Sunrise Technologies WALI wireless parking lot controller. This advanced LED ... minimizing glare, reducing light trespass, and protecting the night sky against light pollution. ...
(Date:9/1/2020)... ... 2020 , ... KitoTech Medical, a Seattle-based medical device company, ... be used to accelerate the commercialization of its microMend® family of wound closure ... to expand its customer base of healthcare systems as well as independent hospitals ...
(Date:9/1/2020)... , ... September 01, 2020 , ... ... with specialty fellowship training in aesthetic surgery of the face, breast, and body. ... the only female-owned premier boutique plastic surgery and aesthetic practice in Southwest Florida. ...
(Date:8/31/2020)... ... ... Just found out your dear friend has cancer? , It’s hard to hear your doctor ... their diagnosis. Once the shock wears off, the questions and fears can be overwhelming. , ... ways to help? Words are failing me. I’m scared. I want to DO something. , ...
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... cloud-based business management solution for chiropractors, announced today the launch of its integrated, ... professionals can start running their virtual practice in under 90 seconds. , ...
Breaking Medicine News(10 mins):
(Date:9/3/2020)... ... September 03, 2020 , ... Q&J Face Masks announced ... an aerosol and engineering lab, conducted tests on Q&J’s personal face mask that ... than many other masks. Q&J face masks have both mechanical filtering and electrostatic ...
(Date:9/2/2020)... ... September 02, 2020 , ... ... Covid-19 , Advanced Penetration Technology, LLC, (APT) a Texas- and Indiana-based company ... non-prescription, Over The Counter (OTC) products, was today provided results of an ...
(Date:9/1/2020)... ... September 01, 2020 , ... ... appointed to serve as Secretary to the Board of Trustees and committee chair ... High United Way is a Denver-based nonprofit organization that fights for the education, ...
Breaking Medicine Technology:
Cached News: